Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo E Rodriguez

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Diagnostics (Basel, Switzerland)|April 13, 2023
High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized DataAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Ramon Mieres, et al.
The International Journal of Cardiovascular Imaging|July 6, 2006
Modified scan protocol using multislice CT coronary angiography allows high quality acquisitions in obese patients: a case reportGastón A Rodriguez-Granillo, Miguel A Rosales, Elina Degrossi, et al.
The International Journal of Cardiovascular Imaging|October 10, 2006
Multislice CT coronary angiography for the detection of burden, morphology and distribution of atherosclerotic plaques in the left main bifurcationGastón A Rodriguez-Granillo, Miguel A Rosales, Elina Degrossi, et al.
Current Pharmaceutical Design|January 9, 2018
Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysisAlfredo E Rodriguez, Alfredo M Rodriguez-Granillo, Sergio D Ascarrunz, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 10, 2018
Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: The ERACI risk scoreAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
The Journal of Invasive Cardiology|August 5, 2009
New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registryGilberto Perez, Alfredo M Rodriguez-Granillo, Juan Mieres, et al.
The Journal of Invasive Cardiology|October 2, 2003
Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial)Alfredo E Rodriguez, Maximo Rodriguez Alemparte, Cesar F Vigo, et al.
Minerva Cardioangiologica|October 28, 2016
Second vs. first-generation drug-eluting stents in complex lesions subsets: 3 years' follow-up of ERACI IV studyAlfredo E Rodriguez, Omar Santaera, Miguel Larribau, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2012
One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)Juan Mieres, Carlos Fernandez-Pereira, Gustavo Risau, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 24, 2013
Drug-coated balloons for de novo coronary lesions: results from the Valentines II trialRon Waksman, Antonio Serra, Joshua P Loh, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|April 13, 2023
High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized DataAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Ramon Mieres, et al.
The International Journal of Cardiovascular Imaging|July 6, 2006
Modified scan protocol using multislice CT coronary angiography allows high quality acquisitions in obese patients: a case reportGastón A Rodriguez-Granillo, Miguel A Rosales, Elina Degrossi, et al.
The International Journal of Cardiovascular Imaging|October 10, 2006
Multislice CT coronary angiography for the detection of burden, morphology and distribution of atherosclerotic plaques in the left main bifurcationGastón A Rodriguez-Granillo, Miguel A Rosales, Elina Degrossi, et al.
Current Pharmaceutical Design|January 9, 2018
Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysisAlfredo E Rodriguez, Alfredo M Rodriguez-Granillo, Sergio D Ascarrunz, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 10, 2018
Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: The ERACI risk scoreAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
The Journal of Invasive Cardiology|August 5, 2009
New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registryGilberto Perez, Alfredo M Rodriguez-Granillo, Juan Mieres, et al.
The Journal of Invasive Cardiology|October 2, 2003
Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial)Alfredo E Rodriguez, Maximo Rodriguez Alemparte, Cesar F Vigo, et al.
Minerva Cardioangiologica|October 28, 2016
Second vs. first-generation drug-eluting stents in complex lesions subsets: 3 years' follow-up of ERACI IV studyAlfredo E Rodriguez, Omar Santaera, Miguel Larribau, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2012
One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)Juan Mieres, Carlos Fernandez-Pereira, Gustavo Risau, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 24, 2013
Drug-coated balloons for de novo coronary lesions: results from the Valentines II trialRon Waksman, Antonio Serra, Joshua P Loh, et al.
Pageof 6